Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial

被引：0
作者：
Le Zhang
Weixue Wang
Shaohua Ge
Hongli Li
Ming Bai
Jingjing Duan
Yuchong Yang
Tao Ning
Rui Liu
Xia Wang
Zhi Ji
Feixue Wang
Haiyang Zhang
Yi Ba
Ting Deng
机构：
[1] Tianjin Medical University Cancer Institute and Hospital,Department of GI Medical Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer
[2] National Clinical Research Center for Cancer,undefined
来源：
BMC Cancer | / 23卷
关键词：
Immune checkpoint inhibitors; Molecular targeted therapy; Sintilimab; Apatinib; Gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 121 条
[71]  
Lv H(undefined)undefined undefined undefined undefined-undefined
[72]  
Liu Y(undefined)undefined undefined undefined undefined-undefined
[73]  
Boku N(undefined)undefined undefined undefined undefined-undefined
[74]  
Ryu MH(undefined)undefined undefined undefined undefined-undefined
[75]  
Kato K(undefined)undefined undefined undefined undefined-undefined
[76]  
Kawazoe A(undefined)undefined undefined undefined undefined-undefined
[77]  
Yamaguchi K(undefined)undefined undefined undefined undefined-undefined
[78]  
Yasui H(undefined)undefined undefined undefined undefined-undefined
[79]  
Lee WS(undefined)undefined undefined undefined undefined-undefined
[80]  
Yang H(undefined)undefined undefined undefined undefined-undefined
3456789101112